Inventor
Catelijne Stortelers
Inventor
Ghent, BE
Overview
Patents· 20 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Kprimary
C07KPeptides33%
A61KPreparations for medical, dental or toiletry purposes28%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations28%
A61MDevices for introducing media into, or onto, the body5%
C12NMicroorganisms or enzymes2%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms2%
G01NInvestigating or analysing materials by determining their chemical or physical properties2%
PatentTitleYear
11,046,773Bispecific CXCR4-CD4 polypeptides with potent anti-HIV activity202111,028,151Monovalent, bivalent and trivalent anti human respiratory syncytial virus (HRSV) nanobody constructs for the prevention and/or treatment of respiratory tract infections202110,875,918P2X7 receptor binders and polypeptides comprising the same202010,865,249Antigen-binding polypeptides directed against CD38202010,550,174Amino acid sequences directed against envelope proteins of a virus and polypeptides comprising the same for the treatment of viral diseases202010,544,216P2X7 receptor antagonists and agonists202010,407,492Amino acid sequences directed against envelope proteins of a virus and polypeptides comprising the same for the treatment of viral diseases201910,273,305Bispecific CXCR4-CD4 polypeptides with potent anti-HIV activity201910,023,633Method for generation of immunoglobulin sequences20189,994,639Biological materials related to CXCR720189,908,935'P2X7 receptor antagonists and agonists'20189,834,595Amino acid sequences directed against envelope proteins of a virus and polypeptides comprising the same for the treatment of viral diseases20179,803,001'Monovalent, bivalent and trivalent anti human respiratory syncytial virus (hRSV) nanobody constructs for the prevention and/or treatment of respiratory tract infections'20179,758,584'Biological materials related to CXCR7'20179,644,022'Amino acid sequences directed against human respiratory syncytial virus (HRSV) and polypeptides comprising the same for the prevention and/or treatment of respiratory tract infections'20179,512,236'Amino acid sequences directed against GPCRS and polypeptides comprising the same for the treatment of GPCR-related diseases and disorders'20169,260,508'Method for generation of immunoglobulin sequences'20169,193,780'Amino acid sequences directed against envelope proteins of a virus and polypeptides comprising the same for the treatment of viral diseases'20158,945,567'Monovalent, bivalent and trivalent anti human respiratory syncytial virus (HRSV) nanobody constructs for the prevention and/or treatment of respiratory tract infections'20158,937,164'Biological materials related to CXCR7'2015Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2015–2021Patents assigned to ABLYNX NV (18)· patent assignee history
2015–2017Patents assigned to STORTELERS CATELIJNE (5)· patent assignee history
2015–2017Patents assigned to DEPLA ERIK (3)· patent assignee history
2015Patents assigned to VANLANDSCHOOT PETER (2)· patent assignee history
2015–2021Based in Ghent, BE· patent location history
2018–2020Patents assigned to UNIV MEDICAL CENTER HAMBURG EPPENDORF (3)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| ABLYNX NV | 18 | 2015–2021 |
| STORTELERS CATELIJNEself | 5 | 2015–2017 |
| DEPLA ERIK | 3 | 2015–2017 |
| UNIV MEDICAL CENTER HAMBURG EPPENDORF | 3 | 2018–2020 |
| VANLANDSCHOOT PETER | 2 | 2015 |
Locations
| Location | Patents | Span |
|---|---|---|
| Ghent, BE | 20 | 2015–2021 |